Why Herbalife Ltd. Stock Bounced Today

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Herbalife Ltd.  (NYSE: HLF  ) were looking healthier today, jumping as much as 26% after the market rejected Bill Ackman's short-selling presentation today. 

So what: Shares of the nutritional supplement seller dropped 12% yesterday after Ackman, the head of Pershing Square Capital Management and an Herbalife short-seller, promised to deliver a "death blow" to the company in a presentation exposing it as a "massive fraud" today. However, that didn't happen. In his argument, Ackman said the company's hiring practices violate U.S labor law, and he again called the multi-level marketer a "pyramid scheme," insisting that sellers make more money for recruiting new members than selling the actual product. Herbalife once again emphatically denied Ackman's claims in a press release following the presentation.

Now what: In its response, Herbalife noted that Ackman reaffirmed that "Herbalife is first and foremost a company with great products that people want," and that millions of customers choose its products. Continuing on, the company said Ackman again "over-promised and under-delivered in his presentation, and merely showed that the facts were on Herbalife's side. As the stock's jump shows, investors clearly agreed, rejecting Ackman's thesis. This saga is far from over as Ackman earlier this year convinced the DOJ to investigate Herbalife, but Herbalife has won this battle, and next time Ackman calls for Wall Street's attention, he likely won't have as much sway.

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 22, 2014, at 4:12 PM, earlcarroll wrote:

    GOOD GOLLY MISS MOLLY ackman promised a torpedo and a bazooka and he delivered a dud bottle rocket that went of in his pants...what a joke of a presentation...stock is up 25 percent...go billy go..schedule another one soon

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3039428, ~/Articles/ArticleHandler.aspx, 11/28/2014 1:16:43 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement